Home > Insider Trading > Filing (0001181431-11-049313)

Filing Details

Accession Number:: 0001181431-11-049313
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2011-09-14 16:59:27
Reporting Period:: 2011-09-12

Filing Date:: 2011-09-14
Accepted Time:: 2011-09-14 16:59:27
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
891288	Questcor Pharmaceuticals Inc	QCOR	Pharmaceutical Preparations (2834)	330476164

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1223697	M Don Bailey	1300 North Kellogg Drive Suite D Anaheim CA 92807	President & Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2011-09-12	7,500	$1.74	107,000	No	4	M	Indirect	Held by the Bailey 1995 Family Trust
Common Stock	Acquisiton	2011-09-12	5,000	$1.74	112,000	No	4	M	Indirect	Held by the Bailey 1995 Family Trust
Common Stock	Acquisiton	2011-09-12	12,500	$1.47	124,500	No	4	M	Indirect	Held by the Bailey 1995 Family Trust
Common Stock	Acquisiton	2011-09-12	2,500	$1.47	127,000	No	4	M	Indirect	Held by the Bailey 1995 Family Trust
Common Stock	Acquisiton	2011-09-12	2,500	$1.47	129,500	No	4	M	Indirect	Held by the Bailey 1995 Family Trust
Common Stock	Disposition	2011-09-12	6,299	$25.28	123,201	No	4	S	Indirect	Held by the Bailey 1995 Family Trust
Common Stock	Disposition	2011-09-12	8,353	$26.26	114,848	No	4	S	Indirect	Held by the Bailey 1995 Family Trust
Common Stock	Disposition	2011-09-12	8,433	$27.25	106,415	No	4	S	Indirect	Held by the Bailey 1995 Family Trust
Common Stock	Disposition	2011-09-12	6,415	$28.09	100,000	No	4	S	Indirect	Held by the Bailey 1995 Family Trust
Common Stock	Disposition	2011-09-12	500	$28.90	99,500	No	4	S	Indirect	Held by the Bailey 1995 Family Trust

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Indirect	Held by the Bailey 1995 Family Trust
No	4	M	Indirect	Held by the Bailey 1995 Family Trust
No	4	M	Indirect	Held by the Bailey 1995 Family Trust
No	4	M	Indirect	Held by the Bailey 1995 Family Trust
No	4	M	Indirect	Held by the Bailey 1995 Family Trust
No	4	S	Indirect	Held by the Bailey 1995 Family Trust
No	4	S	Indirect	Held by the Bailey 1995 Family Trust
No	4	S	Indirect	Held by the Bailey 1995 Family Trust
No	4	S	Indirect	Held by the Bailey 1995 Family Trust
No	4	S	Indirect	Held by the Bailey 1995 Family Trust

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2011-09-12	7,500	$0.00	7,500	$1.74
Common Stock	Stock Option (Right to Buy)	Disposition	2011-09-12	5,000	$0.00	5,000	$1.74
Common Stock	Stock Option (Right to Buy)	Disposition	2011-09-12	12,500	$0.00	12,500	$1.47
Common Stock	Stock Option (Right to Buy)	Disposition	2011-09-12	2,500	$0.00	2,500	$1.47
Common Stock	Stock Option (Right to Buy)	Disposition	2011-09-12	2,500	$0.00	2,500	$1.47

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2016-05-17	No	4	M	Indirect
0	2016-05-17	No	4	M	Indirect
2,500	2016-12-31	No	4	M	Indirect
7,500	2016-12-31	No	4	M	Indirect
0	2016-12-31	No	4	M	Indirect

Footnotes

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.67-$25.65, inclusive. The reporting person undertakes to provide Questcor Pharmaceuticals, Inc., any security holder of Questcor Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote 1 of the Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.67-$26.62, inclusive. The reporting person undertakes to provide Questcor Pharmaceuticals, Inc., any security holder of Questcor Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote 2 of the Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.68-$27.65, inclusive. The reporting person undertakes to provide Questcor Pharmaceuticals, Inc., any security holder of Questcor Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote 3 of the Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.68-$28.51, inclusive. The reporting person undertakes to provide Questcor Pharmaceuticals, Inc., any security holder of Questcor Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote 4 of the Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.69-$29.17, inclusive. The reporting person undertakes to provide Questcor Pharmaceuticals, Inc., any security holder of Questcor Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote 5 of the Form 4.
Stock options were granted under the Questcor Pharmaceuticals, Inc. 2004 Non-Employee Director Equity Incentive Plan on May 18, 2006.
Stock options were fully vested and exercisable as of May 18, 2006.
Stock options were granted under the Questcor Pharmaceuticals, Inc. 2004 Non-Employee Director Equity Incentive Plan on May 18, 2006.
Stock options were fully vested and exercisable as of May 18, 2006.
Stock options were granted under the Questcor Pharmaceuticals, Inc. 2004 Non-Employee Director Equity Incentive Plan on January 1, 2007.
Stock options were fully vested and exercisable as of January 1, 2011.
Stock options were granted under the Questcor Pharmaceuticals, Inc. 2004 Non-Employee Director Equity Incentive Plan on January 1, 2007.
Stock options were fully vested and exercisable as of January 1, 2007.
Stock options were granted under the Questcor Pharmaceuticals, Inc. 2004 Non-Employee Director Equity Incentive Plan on January 1, 2007.
Stock options were fully vested and exercisable as of January 1, 2011.